Medical Blog About Treatment Abroad

Ovarian cancer is one of the most common gynecological malignancies among women in the world. It is the eighth most common cancer, with approximately 313,000 new cases diagnosed in women each year. It can be difficult to detect in the early stages because there are no specific symptoms. The later it is diagnosed, the less favorable...

Endometrial cancer is the most common gynecologic malignancy in Europe. According to the European Cancer Information System (ECIS), supported by the European Network of Cancer Registries (ENCR), there were approximately 125,000 new cases of endometrial cancer diagnosed across Europe in 2022, accounting for nearly...

To understand the scope of the problem, just imagine that nearly 300,000 men are diagnosed with prostate cancer yearly. Stage 4 diagnosis presents serious challenges, but many patients live considerably longer with appropriate treatment – despite the 31% 5-year survival rate. German clinics offer options beyond standard care. These are radioligand...

Cancer is one of the leading causes of death among humanity, with approximately 20 million new cases each year and 9.7 million cancer deaths worldwide. About 1 in 5 people will develop cancer in their lifetime, making it a global health concern. There are different treatment options available, but no one can guarantee a complete cure.

Stage 4 stomach cancer is diagnosed in approximately 30,300 Americans annually, which is 1.5% of all cancers. The highest risk is for people over 55. This type of oncology presents serious challenges, but newer treatments in advanced medical centers improve outcomes. Modern therapies – like HIPEC, PIPAC, and dendritic cell vaccines...

Colorectal cancer, encompassing malignancies of the colon and rectum, stands as the third most prevalent cancer globally and ranks second in cancer-related mortality. In 2020, over 1.9 million new cases were diagnosed worldwide, leading to more than 930,000 deaths. The risk of developing colorectal cancer increases with age, predominantly...

Prostate cancer is the most common type of cancer in men and one of the main causes of death in developed countries of Europe and North America. The incidence of it has risen annually by 3% since 2014. Prostate cancer is the second-leading cause of death among males in the US. According to the American Cancer Society, about 1 in 44 men will die...

Neuroendocrine tumors have shown a significant increase in prevalence over the past two decades. Between 2000 and 2018, the age-standardized incidence increased from 4.9 to 8.2 cases per 100,000 population, with the most pronounced increase being among grade 1 tumors, early stages, and appendix neoplasms. Despite improved diagnostic...